Results 191 to 200 of about 13,427 (242)

Increasing Retention in a Trial by Supporting Basic Psychological Needs for Autonomy, Competence and Relatedness: Developing a Theory‐Informed App‐Based Complex Intervention

Scandinavian Journal of Caring Sciences, Volume 40, Issue 1, March 2026.
ABSTRACT Aims and Objectives Most interventions to improve retention in randomised trials have low or uncertain evidence of effect and are not informed by behaviour change science even though behaviour change is their aim. Self‐Determination Theory is an evidence‐based theory within behaviour change science which argues that supporting basic ...
Anne Poder Petersen, Johannes Martin Schmid, Bjarke Hviid‐Vyff, Hans Jürgen Hoffmann, Jeanette Finderup   +4 more
wiley   +1 more source

Predictive biomarkers in allergen specific immunotherapy

Allergologia et Immunopathologia, 2017
D, Barber, M M, Escribese
openaire   +2 more sources

[Is AIT worth your while? Economic evaluation of allergen-specific immunotherapy (AIT) for otorhinolaryngologists in private practice]. [PDF]

HNO
Reineke U, Cappello C.
europepmc   +1 more source

Engineering Chimeric Hypoallergens for Safer and More Effective House Dust Mite Allergy Vaccines

Clinical &Experimental Allergy, Volume 56, Issue 3, Page 288-290, March 2026.
Eduardo S. da Silva, Antônio M. S. Fernandes, Elisânia F. Silveira, Raphael C. Silva, Leonardo F. Santiago, Luis F. S. Garcés, Sara Huber, Sabrina Wildner, Tafarel A. Souza, Vitor S. Alves, Lorena M. de Souza, Deise S. Vilas‐Bôas, Peter Briza, Peter Lackner, Luis G. C. Pacheco, Neuza M. Alcântara‐Neves, Fatima Ferreira, Carina S. Pinheiro   +17 more
wiley   +1 more source

Risk‐stratified introduction of precautionary allergen‐labeled foods in children with peanut and tree nut allergies

Pediatric Allergy and Immunology, Volume 37, Issue 3, March 2026.
François Graham, Mikaël Frossard, Natalia Gasilova, Fabienne Maréchal, Philippe A. Eigenmann   +4 more
wiley   +1 more source

Multiomics approaches disclose very-early molecular and cellular switches during insect-venom allergen-specific immunotherapy

Hefeng F, Pogorelov D, Bode S, He X, Ramiro-Garcia J, Hedin F, Ammerlaan W, Konstantinou M, Capelle C, Zeng N, Poli A, Domingues O, Montamat G, Hunewald O, Cire S, Baron A, Longworth J, Neuberger-Castillo L, Revets D, Guyonnet L, Demczuk A, Delhalle S, Zimmer J, Benes V, Codreanu-Morel F, Lehners-Weber C, Weets I, Alper P, Brenner D, Gutermuth J, Guérin C, Morisset M, Hentges F, Schneider R, Shamji M, Betsou F, Wilmes P, Glaab E, Goncalves J, Cosma A, Ollert M.   +40 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Allergen-Specific Immunotherapy

2014
Specific immunotherapy was introduced for the treatment of grass pollen-induced hay fever in 1911. The treatment was soon extended to other pollens as well as perennial allergens, and to the treatment of bronchial asthma. Definitive studies of its efficacy for both rhinitis and asthma came only many decades later. Understanding gradually emerged of the
Harold S, Nelson, Philip S, Norman
openaire   +3 more sources

Allergen-specific immunotherapy

Immunology Letters, 2009
Allergy is a significant health problem in industrialized countries and its prevalence is continually on the increase: In 1906, when Clemens von Pirquet introduced the term "allergy" to describe overwhelming pathological reactions of the body caused by contact with antigens, less than 1% of the population were affected.
openaire   +2 more sources

Advances in Allergen-Specific Immunotherapy

Current Drug Targets, 2009
After several decades of controversies, allergen specific immunotherapy (SIT) was recognized as an effective treatment for respiratory and hymenoptera allergy by the World Health Organization in 1998. SIT involves the administration (usually subcutaneous) of increasing doses of allergen in order to achieve a hyposensitization. Moreover, SIT is the only
PASSALACQUA, GIOVANNI, Compalati E, CANONICA, GIORGIO   +2 more
openaire   +3 more sources

Advances in allergen-specific immunotherapy

Expert Opinion on Biological Therapy, 2005
Atopic disease affects approximately 30% of the population in western society. Allergen-specific immunotherapy (SIT) is the only treatment with a long-term effect available at the present time, and has been used successfully in the treatment of a number of allergies for almost 100 years. Despite this success, there is great demand for safer, faster and
Johan, Verhagen, Alison, Taylor, Cezmi A, Akdis, Mübeccel, Akdis   +3 more
openaire   +2 more sources